Conference MEET2WIN Register : https://www.inscription-facile.com/form/myivsgeCHbtzy7DeO0BN stephanie.dhont2018-05-07T14:20:36+02:00 Partagez cette histoire, choisissez votre plate-forme ! FacebookTwitterRedditLinkedInTumblrPinterest Related Posts First US leukemia patient dosed with investigational SMART101 cell therapy First US leukemia patient dosed with investigational SMART101 cell therapy Brenus Pharma and InSphero receive €1.5 million in grants for the collaborative project “STC-1010” Brenus Pharma and InSphero receive €1.5 million in grants for the collaborative project “STC-1010” Genoscience Pharma announces the start of GNS561’s Phase 2b Clinical Trial Genoscience Pharma announces the start of GNS561’s Phase 2b Clinical Trial EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer MPC Therapeutics announces completion of its CHF 1.5M seed-funding round to improve CAR-T cancer therapies. MPC Therapeutics announces completion of its CHF 1.5M seed-funding round to improve CAR-T cancer therapies.
